The landscape of pediatric hepatocellular carcinoma and fibrolamellar carcinoma: A report from the Children’s Hepatic tumors International Collaboration (CHIC)

医学 肝母细胞瘤 内科学 肝细胞癌 临床试验 肿瘤科 疾病 化疗 总体生存率 癌症 癌 前瞻性队列研究 存活率 胃肠病学 疾病控制 外科切除术 全身疗法
作者
Allison F. O'neill,Rudolf Maibach,Mark Krailo,Jin Piao,Dolores H Lopez-Terrada,Rita Alaggio,Yukichi Tanaka,Beate Häberle,Daniël C. Aronson,Eiso Hiyama,Christian Vokuhl,Irene Schmid,Marcio H. Malogolowkin,Rebecka L. Meyers,Piotr Stefan Czauderna,Arun Atreiya Rangaswami
出处
期刊:Cancer [Wiley]
卷期号:132 (11): e70413-e70413
标识
DOI:10.1002/cncr.70413
摘要

BACKGROUND: Pediatric hepatocellular carcinoma (HCC) and fibrolamellar carcinoma (FLC) have historically been studied on prospective trials in aggregate with hepatoblastoma (HB). It is now recognized that both HCC and FLC have unique histologies, characteristic genomics, and a more aggressive clinical course than HB. It is anticipated that data analyzed from patients treated on previously conducted international trials will inform current and future approaches to the study of these rare diseases. METHODS: The Children's Hepatic tumors International Collaboration houses data from clinical trials conducted by three global consortia as well as international registries. Data from patients with HCC or FLC who were enrolled on historic trials designed for patients with HB were analyzed for patient demographics, disease characteristics, treatment, and outcomes. RESULTS: The authors identified 236 patients with pediatric HCC or FLC who were enrolled on trials conducted in the United States, Europe, and Japan. As anticipated, HCC and FLC predominantly affected adolescent patients, and outcomes were generally related to extent of disease and resectability. Independent of histology, upfront resection (p = .004) predicted superior survival, likely reflecting the inadequacies of systemic agents to control disease. Outcomes were comparable across studies, with a 5-year survival rate of 36%, independent of chemotherapy received. Survival was equivalent for patients with HCC and FLC after 7-year follow-up. CONCLUSIONS: Treatment of pediatric HCC and FLC remains challenging. The current results support risk-stratification methods currently under study prospectively and the independent study of these tumors in the future.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
小糖完成签到,获得积分10
刚刚
6666发布了新的文献求助200
1秒前
Cecilia0928完成签到,获得积分10
2秒前
舒服的幻梅完成签到 ,获得积分10
2秒前
缓慢板栗完成签到,获得积分10
2秒前
直率的问筠完成签到 ,获得积分10
2秒前
gali完成签到,获得积分10
3秒前
Whahahaha完成签到 ,获得积分10
3秒前
3秒前
PAN完成签到,获得积分10
3秒前
vergil完成签到,获得积分10
3秒前
长岛冰茶完成签到,获得积分10
3秒前
ewmmel完成签到 ,获得积分10
3秒前
灵巧的青寒完成签到,获得积分10
4秒前
火星上立果完成签到,获得积分10
4秒前
5秒前
6秒前
李五可完成签到,获得积分10
6秒前
研友_LBorkn发布了新的文献求助10
6秒前
7秒前
聪慧的碧空完成签到 ,获得积分10
7秒前
武百招完成签到,获得积分10
7秒前
李小明完成签到,获得积分10
7秒前
SZNora完成签到 ,获得积分10
7秒前
smartboy完成签到,获得积分10
7秒前
薰衣草完成签到,获得积分10
8秒前
112233完成签到,获得积分10
8秒前
曹博完成签到,获得积分10
9秒前
牟前苇发布了新的文献求助10
9秒前
9秒前
落落完成签到 ,获得积分10
9秒前
石头完成签到,获得积分10
9秒前
Lan完成签到 ,获得积分10
9秒前
冯冯冯完成签到,获得积分10
9秒前
冲冲冲完成签到,获得积分10
10秒前
外向语堂发布了新的文献求助10
10秒前
剁手党完成签到,获得积分10
11秒前
GHL完成签到,获得积分10
11秒前
芋圆完成签到,获得积分10
11秒前
11秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8159212
求助须知:如何正确求助?哪些是违规求助? 9554678
关于积分的说明 21720538
捐赠科研通 7748887
什么是DOI,文献DOI怎么找? 3427184
关于科研通互助平台的介绍 2552092
邀请新用户注册赠送积分活动 2471464